$VRTX
VERTEX PHARMACEUTICALS INC / MA Stock $vrtx

$vrtx Overview Financials Valuation SEC Filings Company Website

2015 Q4 Form 10-K Financial Statement

#000087532017000017 Filed on February 23, 2017

Income Statement

Concept	2015 Q4	2015 Q3	2015 Q2
Revenue	$417.9M	$309.8M	$166.1M
YoY Change	189.12%	73.09%	19.98%
Cost Of Revenue	$62.09M	$30.27M	$15.41M
YoY Change	449.97%	196.52%	59.6%
Gross Profit	$355.8M	$279.5M	$150.7M
YoY Change	167.02%	65.63%	17.01%
Gross Profit Margin	85.14%	90.23%	90.72%
Selling, General & Admin	$96.55M	$99.77M	$94.39M
YoY Change	22.95%	32.63%	21.88%
% of Gross Profit	27.13%	35.69%	62.65%
Research & Development	$310.2M	$246.3M	$223.9M
YoY Change	53.96%	28.99%	-0.28%
% of Gross Profit	87.17%	88.1%	148.58%
Depreciation & Amortization	$15.70M	$16.20M	$14.00M
YoY Change	-4.27%	-4.14%	-1.41%
% of Gross Profit	4.41%	5.8%	9.29%
Operating Expenses	$406.7M	$346.1M	$318.3M
YoY Change	45.27%	30.02%	5.4%
Operating Profit	-$53.70M	-$70.03M	-$171.2M
YoY Change	-65.04%	-50.76%	-5.19%
Interest Expense	-$20.65M	-$21.13M	-$21.11M
YoY Change	-2.47%	3.68%	35.46%
% of Operating Profit
Other Income/Expense, Net	-$1.690M	-$1.326M	$1.414M
YoY Change	-55.43%	-66.77%	-96.25%
Pretax Income	-$76.05M	-$92.49M	-$190.9M
YoY Change	-57.42%	-44.48%	20.5%
Income Tax	-$1.379M	$1.330M	$30.13M
% Of Pretax Income
Net Earnings	-$73.73M	-$95.15M	-$188.8M
YoY Change	-58.26%	-44.05%	18.49%
Net Earnings / Revenue	-17.64%	-30.71%	-113.71%
Basic Earnings Per Share		-$0.39	-$0.78
Diluted Earnings Per Share	-$303.3K	-$0.39	-$0.78
COMMON SHARES
Basic Shares Outstanding	245.7M shares	242.0M shares	240.8M shares
Diluted Shares Outstanding		242.0M shares	240.8M shares

Balance Sheet

Concept	2015 Q4	2015 Q3	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.042B	$1.006B	$1.016B
YoY Change	-24.87%	-31.94%	-16.65%
Cash & Equivalents	$714.8M	$756.3M	$870.5M
Short-Term Investments	$328.0M	$250.0M	$146.0M
Other Short-Term Assets	$12.84M	$139.0M	$141.0M
YoY Change	83.3%	239.02%	314.71%
Inventory	$57.21M	$49.20M	$42.11M
Prepaid Expenses	$22.06M
Receivables	$173.8M	$165.3M	$94.52M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.407B	$1.359B	$1.295B
YoY Change	-9.01%	-17.61%	-3.91%
LONG-TERM ASSETS
Property, Plant & Equipment	$697.7M	$706.7M	$713.4M
YoY Change	-2.53%	-1.97%	-2.28%
Goodwill	$50.40M	$50.38M	$50.38M
YoY Change	26.27%	62.57%	62.57%
Intangibles
YoY Change
Long-Term Investments	$0.00
YoY Change
Other Assets	$6.912M	$11.06M	$9.136M
YoY Change	111.7%	176.59%	-1.92%
Total Long-Term Assets	$1.091B	$1.075B	$1.079B
YoY Change	38.48%	42.14%	40.1%
TOTAL ASSETS
Total Short-Term Assets	$1.407B	$1.359B	$1.295B
Total Long-Term Assets	$1.091B	$1.075B	$1.079B
Total Assets	$2.499B	$2.434B	$2.374B
YoY Change	7.02%	1.16%	12.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$74.94M	$78.90M	$72.70M
YoY Change	5.26%	105.08%	31.32%
Accrued Expenses	$305.8M	$249.7M	$206.0M
YoY Change	45.85%	2.22%	-13.36%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$87.00M	$14.00M	$57.00M
YoY Change	171.88%	-22.22%	185.0%
Total Short-Term Liabilities	$506.2M	$375.0M	$373.8M
YoY Change	37.45%	0.75%	2.99%
LONG-TERM LIABILITIES
Long-Term Debt	$739.0M	$807.0M	$768.0M
YoY Change	-6.81%	-0.37%	48.26%
Other Long-Term Liabilities	$31.78M	$34.99M	$41.25M
YoY Change	46.4%	119.37%	163.32%
Total Long-Term Liabilities	$31.78M	$34.99M	$41.25M
YoY Change	46.4%	119.37%	163.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$506.2M	$375.0M	$373.8M
Total Long-Term Liabilities	$31.78M	$34.99M	$41.25M
Total Liabilities	$1.405B	$1.357B	$1.326B
YoY Change	13.44%	8.57%	40.22%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.262B	-$5.188B	-$5.093B
YoY Change	11.82%	14.56%	16.84%
Common Stock	$6.200B	$6.109B	$5.990B
YoY Change	7.27%	7.48%	8.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$940.0M	$922.1M	$895.0M
YoY Change
Total Liabilities & Shareholders Equity	$2.499B	$2.434B	$2.374B
YoY Change	7.02%	1.16%	12.1%

Cashflow Statement

Concept	2015 Q4	2015 Q3	2015 Q2
OPERATING ACTIVITIES
Net Income	-$73.73M	-$95.15M	-$188.8M
YoY Change	-58.26%	-44.05%	18.49%
Depreciation, Depletion And Amortization	$15.70M	$16.20M	$14.00M
YoY Change	-4.27%	-4.14%	-1.41%
Cash From Operating Activities	$29.20M	-$62.10M	-$110.3M
YoY Change	-116.06%	-29.11%	-13.76%
INVESTING ACTIVITIES
Capital Expenditures	-$12.50M	-$8.800M	-$13.40M
YoY Change	-14.97%	-5.38%	14.53%
Acquisitions
YoY Change
Other Investing Activities	-$110.1M	-$92.20M	$291.9M
YoY Change	3236.36%	-331.66%	187.3%
Cash From Investing Activities	-$122.6M	-$101.0M	$278.5M
YoY Change	581.11%	-431.15%	209.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	52.60M	49.70M	36.20M
YoY Change	-51.34%	-86.09%	8.38%
NET CHANGE
Cash From Operating Activities	29.20M	-62.10M	-110.3M
Cash From Investing Activities	-122.6M	-101.0M	278.5M
Cash From Financing Activities	52.60M	49.70M	36.20M
Net Change In Cash	-40.80M	-113.4M	204.4M
YoY Change	-55.51%	-137.77%	-4543.48%
FREE CASH FLOW
Cash From Operating Activities	$29.20M	-$62.10M	-$110.3M
Capital Expenditures	-$12.50M	-$8.800M	-$13.40M
Free Cash Flow	$41.70M	-$53.30M	-$96.90M
YoY Change	-124.96%	-31.93%	-16.61%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016	dei	Amendment Flag AmendmentFlag	false
CY2016	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2016	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016	dei	Document Period End Date DocumentPeriodEndDate	2016-12-31
CY2016	dei	Document Type DocumentType	10-K
CY2016	dei	Entity Central Index Key EntityCentralIndexKey	0000875320
CY2017Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	248438127	shares
CY2016	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2016	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q2	dei	Entity Public Float EntityPublicFloat	21100000000	USD
CY2016	dei	Entity Registrant Name EntityRegistrantName	VERTEX PHARMACEUTICALS INC / MA
CY2016	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2016	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	74942000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	61451000	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	173838000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	201083000	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	30953000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	6883000	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	305820000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	315249000	USD
CY2015Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	7455000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	6512000	USD
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	246306818	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	248300517	shares
CY2015Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	60191000	USD
CY2016Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	52845000	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	336067000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	387798000	USD
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-1000000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-2100000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-7900000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1824000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	21173000	USD
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6197500000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	21995000	USD
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	6506795000	USD
CY2014	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	2160000	USD
CY2015	us-gaap	Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet	0	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	178965000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	235112000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	241239000	USD
CY2014	us-gaap	Advertising Expense AdvertisingExpense	16200000	USD
CY2015	us-gaap	Advertising Expense AdvertisingExpense	24500000	USD
CY2016	us-gaap	Advertising Expense AdvertisingExpense	31400000	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	177542000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	231025000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	237705000	USD
CY2014	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1689000	USD
CY2015	us-gaap	Asset Impairment Charges AssetImpairmentCharges	2516000	USD
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2015Q4	us-gaap	Assets Assets	2498587000	USD
CY2016Q4	us-gaap	Assets Assets	2896787000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	1407153000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	1831540000	USD
CY2015Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	327694000	USD
CY2016Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	250612000	USD
CY2014	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	0	USD
CY2015	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	0	USD
CY2016	us-gaap	Available For Sale Securities Gross Realized Gains Losses Sale Proceeds AvailableForSaleSecuritiesGrossRealizedGainsLossesSaleProceeds	0	USD
CY2015Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	15545000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	19426000	USD
CY2014	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	9188000	USD
CY2015	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2016	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	0	USD
CY2015Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	42923000	USD
CY2016Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	34976000	USD
CY2015Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	106800000	USD
CY2016Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	101300000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	58502000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	2457000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	3336000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	8778000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	21393000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	543000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	4100000	USD
CY2016Q4	us-gaap	Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments	54402000	USD
CY2015Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	30400000	USD
CY2016Q4	us-gaap	Capital Leases Lessee Balance Sheet Assets By Major Class Accumulated Deprecation CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation	37900000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	569299000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	625259000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	714768000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1183945000	USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	246306818	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	248300517	shares
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	2427000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	2450000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-737332000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-555427000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-92703000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-4190000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-31847000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	28021000	USD
CY2014	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-741522000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-587274000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-64682000	USD
CY2014	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	637000	USD
CY2015	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	361000	USD
CY2016	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	68000	USD
CY2015Q4	us-gaap	Cost Method Investments CostMethodInvestments	0	USD
CY2016Q4	us-gaap	Cost Method Investments CostMethodInvestments	20276000	USD
CY2014	us-gaap	Cost Of Goods Sold CostOfGoodsSold	39725000	USD
CY2015Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	9381000	USD
CY2015Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	15409000	USD
CY2015Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	30269000	USD
CY2015Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	62092000	USD
CY2015	us-gaap	Cost Of Goods Sold CostOfGoodsSold	117151000	USD
CY2016Q1	us-gaap	Cost Of Goods Sold CostOfGoodsSold	49789000	USD
CY2016Q2	us-gaap	Cost Of Goods Sold CostOfGoodsSold	44154000	USD
CY2016Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	53222000	USD
CY2016Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	59646000	USD
CY2016	us-gaap	Cost Of Goods Sold CostOfGoodsSold	206811000	USD
CY2014	us-gaap	Costs And Expenses CostsAndExpenses	1272827000	USD
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	310494000	USD
CY2015Q2	us-gaap	Costs And Expenses CostsAndExpenses	337240000	USD
CY2015Q3	us-gaap	Costs And Expenses CostsAndExpenses	379842000	USD
CY2015Q4	us-gaap	Costs And Expenses CostsAndExpenses	471639000	USD
CY2015	us-gaap	Costs And Expenses CostsAndExpenses	1499215000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	412410000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	428255000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	432510000	USD
CY2016Q4	us-gaap	Costs And Expenses CostsAndExpenses	419066000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	1692241000	USD
CY2014	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2853000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	25623000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-3821000	USD
CY2014	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	2457000	USD
CY2015	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	831000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1794000	USD
CY2014	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6676000	USD
CY2015	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	30083000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-191000	USD
CY2014	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1366000	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	3629000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1836000	USD
CY2015Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	0	USD
CY2016Q4	us-gaap	Customer Deposits Current CustomerDepositsCurrent	73416000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	244000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	497000	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	18659000	USD
CY2014	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-355000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-3359000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	282000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	298000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	16856000	USD
CY2015Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	22235000	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	19551000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	16296000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	6005000	USD
CY2015Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	9714000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	6632000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	38000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	156000	USD
CY2016	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1556000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	9341000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	31205000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1893216000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1981935000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	5913000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	4705000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	176867000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	250749000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1250642000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1232399000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	22000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	315535000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	367402000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	93404000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	110446000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	222000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Unrealized Currency Losses DeferredTaxAssetsUnrealizedCurrencyLosses	0	USD
CY2015Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Unrealized Losses On Trading Securities DeferredTaxAssetsUnrealizedLossesOnTradingSecurities	5000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1716349000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1731186000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	110084000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	133727000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	110439000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	134063000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	1088000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Investments DeferredTaxLiabilitiesInvestments	7967000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	110439000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	134063000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	175424000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	169089000	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	0	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Tax Deferred Income DeferredTaxLiabilitiesTaxDeferredIncome	73357000	USD
CY2016Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	0	USD
CY2014	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	12000000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	12800000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	11800000	USD
CY2014	us-gaap	Depreciation Depreciation	62300000	USD
CY2015	us-gaap	Depreciation Depreciation	60000000	USD
CY2016	us-gaap	Depreciation Depreciation	60800000	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	63257000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	62343000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61398000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	5766000	USD
CY2015Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	901000	USD
CY2014	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	21262000	USD
CY2015Q1	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	2926000	USD
CY2015Q2	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	1451000	USD
CY2015Q3	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	1691000	USD
CY2015Q4	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	1293000	USD
CY2015	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	7361000	USD
CY2016Q1	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	860000	USD
CY2016Q2	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	1098000	USD
CY2016Q3	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	855000	USD
CY2016Q4	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	836000	USD
CY2016	us-gaap	Direct Operating Cost Royalty Expense DirectOperatingCostRoyaltyExpense	3649000	USD
CY2014	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2015	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2016	us-gaap	Discontinued Operation Tax Effect Of Discontinued Operation DiscontinuedOperationTaxEffectOfDiscontinuedOperation	0	USD
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.14
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.31
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2016Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.46
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.83
CY2015Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.78
CY2015Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.39
CY2015Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.30
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.14
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.31
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2016Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.13
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.46
CY2014	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-2176000	USD
CY2015	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-2834000	USD
CY2016	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations	-4666000	USD
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	87873000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	86387000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1423000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	4087000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	3607000	USD
CY2014	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	255500000	USD
CY2015	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	165600000	USD
CY2016	us-gaap	Employee Service Share Based Compensation Cash Received From Exercise Of Stock Options EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions	48500000	USD
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	2160000	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2016	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
CY2014	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	2160000	USD
CY2015	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0	USD
CY2016	us-gaap	Excess Tax Benefit From Share Based Compensation Operating Activities ExcessTaxBenefitFromShareBasedCompensationOperatingActivities	0	USD
CY2015Q4	us-gaap	Foreign Currency Cash Flow Hedge Derivative At Fair Value Net ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet	5161000	USD
CY2016Q4	us-gaap	Foreign Currency Cash Flow Hedge Derivative At Fair Value Net ForeignCurrencyCashFlowHedgeDerivativeAtFairValueNet	14407000	USD
CY2014	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6400000	USD
CY2015	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-6800000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	4000000	USD
CY2016Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions FutureMinimumSubleaseRentalsSaleLeasebackTransactions	20923000	USD
CY2016Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Thereafter FutureMinimumSubleaseRentalsSaleLeasebackTransactionsThereafter	0	USD
CY2016Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Five Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFiveYears	0	USD
CY2016Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Four Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinFourYears	0	USD
CY2016Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within One Year FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear	15687000	USD
CY2016Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Three Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinThreeYears	0	USD
CY2016Q4	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears	5236000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	50384000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	50400000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	50384000	USD
CY2014	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2015	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2016	us-gaap	Impairment Of Investments ImpairmentOfInvestments	0	USD
CY2014	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-737643000	USD
CY2015	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-556334000	USD
CY2016	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-112052000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-4190000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-31847000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	28021000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-645465000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-272326000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-147860000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-89410000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-285474000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	80494000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-734875000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-198405000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-190861000	USD
CY2015Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-92486000	USD
CY2015Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-76048000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-557800000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-30617000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-18021000	USD
CY2016Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-39034000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	20306000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-67366000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-741833000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-588181000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-84031000	USD
CY2014	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-3.14
CY2015	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-2.31
CY2016	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.46
CY2014	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-3.14
CY2015	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-2.31
CY2016	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	-0.46
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-912000	USD
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	0	USD
CY2015Q1	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-98000	USD
CY2015Q2	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-32144000	USD
CY2015Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	1333000	USD
CY2015Q4	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Noncontrolling Interest IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest	-938000	USD
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	-912000	USD
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity	0	USD
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare	0.00
CY2014	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2015	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2016	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare	0.00
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6958000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	299000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30131000	USD
CY2015Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1330000	USD
CY2015Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1379000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30381000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5485000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18130000	USD
CY2016Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	503000	USD
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7453000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16665000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	14800000	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-1826000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-1224000	USD
CY2016	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	12836000	USD
CY2014	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	39335000	USD
CY2015	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	47402000	USD
CY2016	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	21346000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-257206000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-195230000	USD
CY2016	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-23578000	USD
CY2014	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	18756000	USD
CY2015	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	5817000	USD
CY2016	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	24749000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-474000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-657000	USD
CY2016	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	680000	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1124000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3800000	USD
CY2016	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	3621000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	33788000	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	55696000	USD
CY2016	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	47773000	USD
CY2014	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1210000	USD
CY2015	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1806000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-2579000	USD
CY2015Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	14682000	USD
CY2016Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	3213000	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	25048000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1709000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-11745000	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-7428000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	104847000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	33027000	USD
CY2014	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-63183000	USD
CY2015	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	102746000	USD
CY2016	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	88649000	USD
CY2014	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-25531000	USD
CY2015	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-19242000	USD
CY2016	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-13372000	USD
CY2014	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16469000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	23146000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	16450000	USD
CY2014	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	281000	USD
CY2015	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	3283000	USD
CY2016	us-gaap	Increase Decrease In Other Deferred Liability IncreaseDecreaseInOtherDeferredLiability	16961000	USD
CY2014	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	15771000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9260000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8699000	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	21981000	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-22029000	USD
CY2014	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-1638000	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-11685000	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash And Investments IncreaseDecreaseInRestrictedCashAndInvestments	-31148000	USD
CY2015Q2	us-gaap	Indefinitelived Intangible Assets Acquired IndefinitelivedIntangibleAssetsAcquired	255300000	USD
CY2014	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-72863000	USD
CY2015Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-21307000	USD
CY2015Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-21111000	USD
CY2015Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-21134000	USD
CY2015Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20654000	USD
CY2015	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-84206000	USD
CY2016Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20698000	USD
CY2016Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20155000	USD
CY2016Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20140000	USD
CY2016Q4	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-20439000	USD
CY2016	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-81432000	USD
CY2014	us-gaap	Interest Paid InterestPaid	68963000	USD
CY2015	us-gaap	Interest Paid InterestPaid	85613000	USD
CY2016	us-gaap	Interest Paid InterestPaid	83656000	USD
CY2015Q4	us-gaap	Interest Payable Current InterestPayableCurrent	4642000	USD
CY2016Q4	us-gaap	Interest Payable Current InterestPayableCurrent	1390000	USD
CY2015Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7816000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	14584000	USD
CY2015Q4	us-gaap	Inventory Net InventoryNet	57207000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	77604000	USD
CY2015Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	8696000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6348000	USD
CY2015Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	40695000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	56672000	USD
CY2014	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	38900000	USD
CY2015	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	18100000	USD
CY2016	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	19100000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	1404959000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	1558596000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2498587000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2896787000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	506167000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	792537000	USD
CY2015Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2016Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	300000000	USD
CY2016Q4	us-gaap	Loans Payable LoansPayable	300000000	USD
CY2015Q4	us-gaap	Minority Interest MinorityInterest	153661000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	181609000	USD
CY2014	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	55960000	USD
CY2015	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	89509000	USD
CY2016	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	469177000	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	549239000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	188919000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	133271000	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	82009000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	268856000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	104469000	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-573112000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-365432000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	236103000	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-738555000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-198606000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	-188848000	USD
CY2015Q3	us-gaap	Net Income Loss NetIncomeLoss	-95149000	USD
CY2015Q4	us-gaap	Net Income Loss NetIncomeLoss	-73731000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-556334000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-41631000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-64525000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-38841000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	32945000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-112052000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	5529000	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	28374000	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-696000	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5186000	USD
CY2014	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	25564000	USD
CY2015	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	14238000	USD
CY2015	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	164317000	USD
CY2014	us-gaap	Noncontrolling Interest Increase From Sale Of Parent Equity Interest NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest	25367000	USD
CY2015Q4	us-gaap	Noncurrent Assets NoncurrentAssets	697715000	USD
CY2016Q4	us-gaap	Noncurrent Assets NoncurrentAssets	698362000	USD
CY2015Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	30000000	USD
CY2016Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	0	USD
CY2014	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2015	us-gaap	Notes Issued1 NotesIssued1	0	USD
CY2016	us-gaap	Notes Issued1 NotesIssued1	225000000	USD
CY2016	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-692412000	USD
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-171985000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-171164000	USD
CY2015Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-70026000	USD
CY2015Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-53704000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-466879000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-14330000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	3353000	USD
CY2016Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-18727000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	39640000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	9936000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	1184689000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	87910000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	92097000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	92897000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	91241000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	84886000	USD
CY2016Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	735658000	USD
CY2015Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11820000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11943000	USD
CY2015Q4	us-gaap	Other Assets Current OtherAssetsCurrent	12835000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	16780000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	6912000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11833000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-646000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1109000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5782000	USD
CY2014	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1223000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	907000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	19349000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	2034000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	1767000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	7736000	USD
CY2014	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-165000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	249000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	17395000	USD
CY2015Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	284340000	USD
CY2016Q4	us-gaap	Other Indefinite Lived Intangible Assets OtherIndefiniteLivedIntangibleAssets	284340000	USD
CY2015Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14374000	USD
CY2016Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10943000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	31778000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	102122000	USD
CY2014	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	USD
CY2015	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9532000	USD
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-6140000	USD
CY2014Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	36700000	USD
CY2014Q2	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	36700000	USD
CY2014	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	30400000	USD
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5113000	USD
CY2015Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1414000	USD
CY2015Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1326000	USD
CY2015Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1690000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6715000	USD
CY2016Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4411000	USD
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1219000	USD
CY2016Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-167000	USD
CY2016Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1105000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4130000	USD
CY2015Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	9543000	USD
CY2016Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	9148000	USD
CY2014	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	244000	USD
CY2015	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-52000	USD
CY2016	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7000	USD
CY2014	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	3103000	USD
CY2014	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	1424172000	USD
CY2015	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	633041000	USD
CY2016	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	616625000	USD
CY2014	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	10000000	USD
CY2015	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	80000000	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
CY2014	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
CY2015	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	30000000	USD
CY2016	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	20000000	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	51201000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	45302000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	56563000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	54736000	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	70534000	USD
CY2015Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	22058000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	36134000	USD
CY2014	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	294243000	USD
CY2015	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2016	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	274615000	USD
CY2015	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	185592000	USD
CY2016	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	68230000	USD
CY2014	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	0	USD
CY2015	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	23662000	USD
CY2016	us-gaap	Proceeds From Long Term Capital Lease Obligations ProceedsFromLongTermCapitalLeaseObligations	11208000	USD
CY2014	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2015	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2016	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	74965000	USD
CY2014	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1557938000	USD
CY2015	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	1067443000	USD
CY2016	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	757562000	USD
CY2014	us-gaap	Profit Loss ProfitLoss	-742745000	USD
CY2015Q1	us-gaap	Profit Loss ProfitLoss	-198704000	USD
CY2015Q2	us-gaap	Profit Loss ProfitLoss	-220992000	USD
CY2015Q3	us-gaap	Profit Loss ProfitLoss	-93816000	USD
CY2015Q4	us-gaap	Profit Loss ProfitLoss	-74669000	USD
CY2015	us-gaap	Profit Loss ProfitLoss	-588181000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-36102000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	-36151000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	-39537000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	27759000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-84031000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1033782000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1086160000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	697715000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	698362000	USD
CY2014	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	21443000	USD
CY2015	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	19954000	USD
CY2016	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	17597000	USD
CY2014	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2015	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2016	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	75000000	USD
CY2014	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	855506000	USD
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	215599000	USD
CY2015Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	223858000	USD
CY2015Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	246284000	USD
CY2015Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	310181000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	995922000	USD
CY2016Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	255860000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	271008000	USD
CY2016Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	272370000	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	248452000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1047690000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	78910000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	47762000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	22083000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	52000	USD
CY2014	us-gaap	Restructuring Charges RestructuringCharges	50925000	USD
CY2015Q1	us-gaap	Restructuring Charges RestructuringCharges	-3272000	USD
CY2015Q2	us-gaap	Restructuring Charges RestructuringCharges	2128000	USD
CY2015Q3	us-gaap	Restructuring Charges RestructuringCharges	1826000	USD
CY2015Q4	us-gaap	Restructuring Charges RestructuringCharges	1524000	USD
CY2015	us-gaap	Restructuring Charges RestructuringCharges	2206000	USD
CY2016Q1	us-gaap	Restructuring Charges RestructuringCharges	687000	USD
CY2016Q2	us-gaap	Restructuring Charges RestructuringCharges	343000	USD
CY2016Q3	us-gaap	Restructuring Charges RestructuringCharges	8000	USD
CY2016Q4	us-gaap	Restructuring Charges RestructuringCharges	224000	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	1262000	USD
CY2015Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	7894000	USD
CY2016Q4	us-gaap	Restructuring Reserve Current RestructuringReserveCurrent	6047000	USD
CY2015Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	7464000	USD
CY2016Q4	us-gaap	Restructuring Reserve Noncurrent RestructuringReserveNoncurrent	1907000	USD
CY2014	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	17502000	USD
CY2015	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	-30492000	USD
CY2016	us-gaap	Restructuring Reserve Period Increase Decrease RestructuringReservePeriodIncreaseDecrease	-7426000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5261784000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5373836000	USD
CY2014	us-gaap	Revenues Revenues	580415000	USD
CY2015Q1	us-gaap	Revenues Revenues	138509000	USD
CY2015Q2	us-gaap	Revenues Revenues	166076000	USD
CY2015Q3	us-gaap	Revenues Revenues	309816000	USD
CY2015Q4	us-gaap	Revenues Revenues	417935000	USD
CY2015	us-gaap	Revenues Revenues	1032336000	USD
CY2016Q1	us-gaap	Revenues Revenues	398080000	USD
CY2016Q2	us-gaap	Revenues Revenues	431608000	USD
CY2016Q3	us-gaap	Revenues Revenues	413783000	USD
CY2016Q4	us-gaap	Revenues Revenues	458706000	USD
CY2016	us-gaap	Revenues Revenues	1702177000	USD
CY2014	us-gaap	Royalty Revenue RoyaltyRevenue	40919000	USD
CY2015Q1	us-gaap	Royalty Revenue RoyaltyRevenue	6792000	USD
CY2015Q2	us-gaap	Royalty Revenue RoyaltyRevenue	5077000	USD
CY2015Q3	us-gaap	Royalty Revenue RoyaltyRevenue	5759000	USD
CY2015Q4	us-gaap	Royalty Revenue RoyaltyRevenue	6331000	USD
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	23959000	USD
CY2016Q1	us-gaap	Royalty Revenue RoyaltyRevenue	3596000	USD
CY2016Q2	us-gaap	Royalty Revenue RoyaltyRevenue	5282000	USD
CY2016Q3	us-gaap	Royalty Revenue RoyaltyRevenue	3835000	USD
CY2016Q4	us-gaap	Royalty Revenue RoyaltyRevenue	3887000	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	16600000	USD
CY2014	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	487821000	USD
CY2015Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	130875000	USD
CY2015Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	160388000	USD
CY2015Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	302511000	USD
CY2015Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	406550000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1000324000	USD
CY2016Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	394410000	USD
CY2016Q2	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	425651000	USD
CY2016Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	409689000	USD
CY2016Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	453882000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	1683632000	USD
CY2014	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	305409000	USD
CY2015Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	85860000	USD
CY2015Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	94394000	USD
CY2015Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	99772000	USD
CY2015Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	96549000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	376575000	USD
CY2016Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	105214000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	111652000	USD
CY2016Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	106055000	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	109908000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	432829000	USD
CY2015Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	223863000	USD
CY2016Q4	us-gaap	Senior Long Term Notes SeniorLongTermNotes	0	USD
CY2015Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	71296000	USD
CY2016Q4	us-gaap	Senior Notes Current SeniorNotesCurrent	0	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	177542000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	231025000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	237705000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	9180002	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7323000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	68.92
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	316500000	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	252900000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	48600000	USD
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	78000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	544000	shares
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	3183000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	124939000	USD
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	11145000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	12642000	shares
CY2015Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	75.99
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	81.41
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	124892000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	12200000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	80.76
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	45.61
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	107.51
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	94.62
CY2016	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	91.36
CY2016Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	7323000	shares
CY2016Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	12642000	shares
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	177542000	USD
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	231025000	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	237705000	USD
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	121671000	USD
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y22D
CY2016	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y
CY2016Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	68.92
CY2016Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	81.41
CY2016	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P7Y22D
CY2016	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1064000	shares
CY2014	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	274808000	USD
CY2015	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	185290000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	68006000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	939967000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1156582000	USD
CY2013Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1356405000	USD
CY2014Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1096183000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1093628000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1338191000	USD
CY2014Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	880000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	425000	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2015	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	455000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2015	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	425000	USD
CY2014	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	3270000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-20852000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	-104000	USD
CY2013Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	87133000	USD
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	36023000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	49296000	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	89201000	USD
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	235307000	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	241312000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	243831000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	244482000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	244920000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	247757000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	244685000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	239493000	shares
CY2015Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	240757000	shares
CY2015Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	241969000	shares
CY2015Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	242987000	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	235307000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	241312000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	243831000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	244482000	shares
CY2016Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	244920000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	245454000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	244685000	shares
CY2015Q4	vrtx	Accrued Research Development And Commercial Contract Costs AccruedResearchDevelopmentAndCommercialContractCosts	55677000	USD
CY2016Q4	vrtx	Accrued Research Development And Commercial Contract Costs AccruedResearchDevelopmentAndCommercialContractCosts	62756000	USD
CY2016	vrtx	Additional Milestone Payments AdditionalMilestonePayments	0	USD
CY2015Q4	vrtx	Cash Cash Equivalents And Available For Sale Securities Fair Value CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue	1042462000	USD
CY2016Q4	vrtx	Cash Cash Equivalents And Available For Sale Securities Fair Value CashCashEquivalentsAndAvailableForSaleSecuritiesFairValue	1434557000	USD
CY2016Q4	vrtx	Cash Cash Equivalents And Marketable Securities CashCashEquivalentsAndMarketableSecurities	1430000000	USD
CY2015Q4	vrtx	Cash Cash Equivalents Available For Sale Securities Amortized Cost CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost	1042336000	USD
CY2016Q4	vrtx	Cash Cash Equivalents Available For Sale Securities Amortized Cost CashCashEquivalentsAvailableForSaleSecuritiesAmortizedCost	1413220000	USD
CY2015Q4	vrtx	Cash Cash Equivalents Availableforsale Securities Gross Unrealized Gain CashCashEquivalentsAvailableforsaleSecuritiesGrossUnrealizedGain	246000	USD
CY2016Q4	vrtx	Cash Cash Equivalents Availableforsale Securities Gross Unrealized Gain CashCashEquivalentsAvailableforsaleSecuritiesGrossUnrealizedGain	21422000	USD
CY2015Q4	vrtx	Cash Cash Equivalents Availableforsale Securities Unrealized Loss Gross CashCashEquivalentsAvailableforsaleSecuritiesUnrealizedLossGross	120000	USD
CY2016Q4	vrtx	Cash Cash Equivalents Availableforsale Securities Unrealized Loss Gross CashCashEquivalentsAvailableforsaleSecuritiesUnrealizedLossGross	85000	USD
CY2015Q4	vrtx	Collaborative Arrangements Advanced Funding Liability Noncurrent CollaborativeArrangementsAdvancedFundingLiabilityNoncurrent	0	USD
CY2016Q4	vrtx	Collaborative Arrangements Advanced Funding Liability Noncurrent CollaborativeArrangementsAdvancedFundingLiabilityNoncurrent	73423000	USD
CY2014	vrtx	Collaborative Revenues CollaborativeRevenues	51675000	USD
CY2015Q1	vrtx	Collaborative Revenues CollaborativeRevenues	842000	USD
CY2015Q2	vrtx	Collaborative Revenues CollaborativeRevenues	611000	USD
CY2015Q3	vrtx	Collaborative Revenues CollaborativeRevenues	1546000	USD
CY2015Q4	vrtx	Collaborative Revenues CollaborativeRevenues	5054000	USD
CY2015	vrtx	Collaborative Revenues CollaborativeRevenues	8053000	USD
CY2016Q1	vrtx	Collaborative Revenues CollaborativeRevenues	74000	USD
CY2016Q2	vrtx	Collaborative Revenues CollaborativeRevenues	675000	USD
CY2016Q3	vrtx	Collaborative Revenues CollaborativeRevenues	259000	USD
CY2016Q4	vrtx	Collaborative Revenues CollaborativeRevenues	937000	USD
CY2016	vrtx	Collaborative Revenues CollaborativeRevenues	1945000	USD
CY2016	vrtx	Common Stock Votes Per Share CommonStockVotesPerShare	1	vote
CY2015Q4	vrtx	Construction Financing Obligation Noncurrent ConstructionFinancingObligationNoncurrent	472611000	USD
CY2016Q4	vrtx	Construction Financing Obligation Noncurrent ConstructionFinancingObligationNoncurrent	486359000	USD
CY2015Q4	vrtx	Constructionfinancingleaseobligationcurrentandnoncurrent Constructionfinancingleaseobligationcurrentandnoncurrent	473000000	USD
CY2016Q4	vrtx	Constructionfinancingleaseobligationcurrentandnoncurrent Constructionfinancingleaseobligationcurrentandnoncurrent	472600000	USD
CY2016Q4	vrtx	Contingent Liabilities ContingentLiabilities	0	USD
CY2016Q4	vrtx	Deferred Revenue Royalty Purchase Agreement DeferredRevenueRoyaltyPurchaseAgreement	12600000	USD
CY2015Q4	vrtx	Deferred Tax Assets Accrued Expenses And Other DeferredTaxAssetsAccruedExpensesAndOther	27236000	USD
CY2016Q4	vrtx	Deferred Tax Assets Accrued Expenses And Other DeferredTaxAssetsAccruedExpensesAndOther	23078000	USD
CY2015Q4	vrtx	Deferred Tax Assets Disregarded Entity Deferrals DeferredTaxAssetsDisregardedEntityDeferrals	176250000	USD
CY2016Q4	vrtx	Deferred Tax Assets Disregarded Entity Deferrals DeferredTaxAssetsDisregardedEntityDeferrals	177735000	USD
CY2015Q4	vrtx	Deferred Tax Assets Intangibles DeferredTaxAssetsIntangibles	14673000	USD
CY2016Q4	vrtx	Deferred Tax Assets Intangibles DeferredTaxAssetsIntangibles	34938000	USD
CY2016Q4	vrtx	Defined Contribution Plan Number Of Shares Available For Grant DefinedContributionPlanNumberOfSharesAvailableForGrant	755000	shares
CY2014	vrtx	Effective Income Tax Rate Reconciliation Tax Attribute Expiration Amount EffectiveIncomeTaxRateReconciliationTaxAttributeExpirationAmount	0	USD
CY2015	vrtx	Effective Income Tax Rate Reconciliation Tax Attribute Expiration Amount EffectiveIncomeTaxRateReconciliationTaxAttributeExpirationAmount	0	USD
CY2016	vrtx	Effective Income Tax Rate Reconciliation Tax Attribute Expiration Amount EffectiveIncomeTaxRateReconciliationTaxAttributeExpirationAmount	9947000	USD
CY2014	vrtx	Income Tax Reconciliation Unbenefited Operating Losses IncomeTaxReconciliationUnbenefitedOperatingLosses	241037000	USD
CY2015	vrtx	Income Tax Reconciliation Unbenefited Operating Losses IncomeTaxReconciliationUnbenefitedOperatingLosses	226169000	USD
CY2016	vrtx	Income Tax Reconciliation Unbenefited Operating Losses IncomeTaxReconciliationUnbenefitedOperatingLosses	14837000	USD
CY2016Q4	vrtx	Indemnification Claims IndemnificationClaims	0	USD
CY2016Q4	vrtx	Line Of Credit Facility Additional Borrowing Capacity LineOfCreditFacilityAdditionalBorrowingCapacity	300000000.0	USD
CY2016	vrtx	Maximum Defined Contribution Plan Employee Contribution Percentage Of Compensation MaximumDefinedContributionPlanEmployeeContributionPercentageOfCompensation	0.6
CY2016Q4	vrtx	Number Of Marketed Medicines NumberOfMarketedMedicines	2	marketed_medecine
CY2015Q4	vrtx	Outstanding Restricted Stock And Restricted Stock Units Grant Price OutstandingRestrictedStockAndRestrictedStockUnitsGrantPrice	10.00
CY2014	vrtx	Paymentson Construction Financing Lease Obligations PaymentsonConstructionFinancingLeaseObligations	336000	USD
CY2015	vrtx	Paymentson Construction Financing Lease Obligations PaymentsonConstructionFinancingLeaseObligations	381000	USD
CY2016	vrtx	Paymentson Construction Financing Lease Obligations PaymentsonConstructionFinancingLeaseObligations	432000	USD
CY2014	vrtx	Paymentto Acquire Preferred Stock PaymenttoAcquirePreferredStock	0	USD
CY2015	vrtx	Paymentto Acquire Preferred Stock PaymenttoAcquirePreferredStock	0	USD
CY2016	vrtx	Paymentto Acquire Preferred Stock PaymenttoAcquirePreferredStock	13075000	USD
CY2016	vrtx	Percentageofemployeeseligibleforaccelerationofequityawards Percentageofemployeeseligibleforaccelerationofequityawards	0.05
CY2014	vrtx	Proceeds From Collaborative Funding ProceedsFromCollaborativeFunding	0	USD
CY2015	vrtx	Proceeds From Collaborative Funding ProceedsFromCollaborativeFunding	0	USD
CY2016	vrtx	Proceeds From Collaborative Funding ProceedsFromCollaborativeFunding	75000000	USD
CY2008	vrtx	Proceeds From Sale Of Royalty Rights ProceedsFromSaleOfRoyaltyRights	160000000	USD
CY2014	vrtx	Proceedsfrom Return Relatedto Financing Lease Obligation ProceedsfromReturnRelatedtoFinancingLeaseObligation	8050000	USD
CY2015	vrtx	Proceedsfrom Return Relatedto Financing Lease Obligation ProceedsfromReturnRelatedtoFinancingLeaseObligation	0	USD
CY2016	vrtx	Proceedsfrom Return Relatedto Financing Lease Obligation ProceedsfromReturnRelatedtoFinancingLeaseObligation	0	USD
CY2015Q4	vrtx	Product Sales Accrued Liabilities ProductSalesAccruedLiabilities	47209000	USD
CY2016Q4	vrtx	Product Sales Accrued Liabilities ProductSalesAccruedLiabilities	86533000	USD
CY2016Q2	vrtx	Researchand Development Expenses Earlystage Research Assets ResearchandDevelopmentExpensesEarlystageResearchAssets	10000000	USD
CY2016Q4	vrtx	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOutstandingNumber	16187626	shares
CY2014	vrtx	Valuation Allowances And Reserves Provision ValuationAllowancesAndReservesProvision	48006000	USD
CY2015	vrtx	Valuation Allowances And Reserves Provision ValuationAllowancesAndReservesProvision	81205000	USD
CY2016	vrtx	Valuation Allowances And Reserves Provision ValuationAllowancesAndReservesProvision	163922000	USD
CY2014	vrtx	Valuation Allowances And Reserves Sales Credits Or Payments Current ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent	102386000	USD
CY2015	vrtx	Valuation Allowances And Reserves Sales Credits Or Payments Current ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent	47080000	USD
CY2016	vrtx	Valuation Allowances And Reserves Sales Credits Or Payments Current ValuationAllowancesAndReservesSalesCreditsOrPaymentsCurrent	123913000	USD
CY2016	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:12px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of consolidated financial statements in accordance with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the amounts of revenues and expenses during the reported periods. Significant estimates in these consolidated financial statements have been made in connection with the calculation of revenues, inventories, research and development expenses, stock-based compensation expense, restructuring expense, the fair value of intangible assets, goodwill, contingent consideration, noncontrolling interest, the consolidation of VIEs, leases, the fair value of cash flow hedges and the provision for or benefit from income taxes. The Company bases its estimates on historical experience and various other assumptions, including in certain circumstances future projections, that management believes to be reasonable under the circumstances. Actual results could differ from those estimates. Changes in estimates are reflected in reported results in the period in which they become known.</font></div></div>

Files In Submission

Name	View Source	Status
0000875320-17-000017-index-headers.html	Edgar Link	pending
0000875320-17-000017-index.html	Edgar Link	pending
0000875320-17-000017.txt	Edgar Link	pending
0000875320-17-000017-xbrl.zip	Edgar Link	pending
a10k_2016-exhibit1012.htm	Edgar Link	pending
a10k_2016-exhibit1013.htm	Edgar Link	pending
a10k_2016-exhibit1040.htm	Edgar Link	pending
a10k_2016-exhibit1041.htm	Edgar Link	pending
a10k_2016-exhibit1042.htm	Edgar Link	pending
a10k_2016-exhibit1043.htm	Edgar Link	pending
a10k_2016-exhibit105.htm	Edgar Link	pending
a10k_2016-exhibit211.htm	Edgar Link	pending
a10k_2016-exhibit231.htm	Edgar Link	pending
a10k_2016-exhibit311.htm	Edgar Link	pending
a10k_2016-exhibit312.htm	Edgar Link	pending
a10k_2016-exhibit321.htm	Edgar Link	pending
a201610k-main.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
grapha17.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vrtx-20161231.xml	Edgar Link	completed
vrtx-20161231.xsd	Edgar Link	pending
vrtx-20161231_cal.xml	Edgar Link	unprocessable
vrtx-20161231_def.xml	Edgar Link	unprocessable
vrtx-20161231_lab.xml	Edgar Link	unprocessable
vrtx-20161231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VRTX
VERTEX PHARMACEUTICALS INC / MA Stock $vrtx

2015 Q4 Form 10-K Financial Statement

#000087532017000017 Filed on February 23, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRTX VERTEX PHARMACEUTICALS INC / MA Stock $vrtx

2015 Q4 Form 10-K Financial Statement

#000087532017000017 Filed on February 23, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VRTX
VERTEX PHARMACEUTICALS INC / MA Stock $vrtx